Emversity
Seed Round in 2025
Emversity is an education organization focused on preparing students for careers in Allied Health Sciences. It offers vocational courses tailored to industry needs, aiming to bridge the gap between education and employment.
Zocks, established in 2022 and based in San Francisco, specializes in real-time video call insights and privacy. The company's core product is a communication management platform, which captures and analyzes industry-specific insights from client conversations. Key features include claim code tracking, data entry reduction, session insights, HIPAA compliance, and API references, helping clients streamline workflows and extract valuable data from conversations.
Frontera Health
Seed Round in 2025
Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases.
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.
Eternal
Seed Round in 2025
With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey.
Neko Health
Series B in 2025
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.
Senseera
Seed Round in 2025
Senseera is a company focused on the development of liquid biopsy blood tests aimed at the early detection and monitoring of cancer and other diseases. By leveraging molecular biology, sequencing technologies, and advanced computational analysis, Senseera extracts epigenetic information from chromatin fragments present in the bloodstream. This innovative approach transforms complex biological data into actionable clinical insights, enabling more accurate and affordable health screenings for patients. Through its cutting-edge technology, Senseera aims to enhance disease detection and improve patient outcomes.
Anatomy Financial
Series A in 2024
Anatomy Financial specializes in streamlining financial operations for healthcare organizations that bill insurance. Their core offering is an AI-driven platform that automates financial workflows, including automated conversion of Explanation of Benefits (EOBs), intelligent reconciliation, and a modern healthcare lockbox system. This platform integrates and analyzes bank, claims, and accounting data in real-time, providing actionable financial insights and automating reconciliation processes. By doing so, Anatomy Financial enables healthcare providers to focus more on patient care.
Soda Health
Series B in 2024
Founded in 2021, Soda Health is a Chicago-based healthcare technology company committed to reducing health disparities by addressing social determinants of health. It operates a platform that delivers personalized benefits, providing real-time access to essential services such as healthy food, over-the-counter medications, and transportation.
XAI is a technology company specializing in artificial intelligence. It creates and deploys AI solutions, primarily using machine learning, to enhance data analysis and decision-making processes. XAI caters to the finance, healthcare, and logistics sectors, aiming to improve accuracy and efficiency in these industries.
Alpha9 Theranostics
Series C in 2024
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets.
Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.
Tennr is a healthcare technology company that develops an AI-powered platform to automate back-office operations in healthcare. The solution replaces traditional fax-based workflows and streamlines communication, enabling timely patient care. It tracks the lifecycle of patient referrals and automates tasks such as data entry verification and workflow progression, reducing manual work for staff and allowing practices of all sizes to optimize back-office processes with enterprise-quality automation.
Air Doctor
Series B in 2024
Air Doctor Ltd. operates an online marketplace that connects travelers with verified healthcare professionals in various locations. Founded in 2016 and based in Motza Illit, Israel, the platform allows users to search for and schedule appointments with doctors, dentists, emergency clinics, pharmacies, and other healthcare specialists. By providing access to practitioner profiles and patient reviews, Air Doctor simplifies the process of obtaining medical care abroad, ensuring that users can find professionals who speak their language and meet their specific needs. This service aims to enhance the experience of travelers by making healthcare access straightforward and efficient in unfamiliar destinations.
Scorpion Therapeutics
Series C in 2024
Founded in 2020 and headquartered in Boston, Massachusetts, Scorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology. It develops targeted small-molecule drugs to treat cancer by focusing on three areas: therapies against known oncogenes, agents for currently undruggable targets, and drugs for new targets.
Qure.ai Technologies Private Limited specializes in developing artificial intelligence software for the healthcare sector, focusing on medical imaging to enhance disease diagnosis from radiology and pathology images. Founded in 2016 and headquartered in Mumbai, India, with a presence in New York, the company offers tools such as qXR, which automates chest X-ray interpretation to identify abnormal findings, including signs of tuberculosis. Qure.ai also provides qER, which assists in triaging critical head CT scans and offers tools for monitoring traumatic brain injury and reporting. By leveraging deep learning solutions, Qure.ai aims to improve the accuracy of diagnoses and make healthcare more affordable and accessible, ultimately allowing healthcare professionals to dedicate more time to patient care.
Pheon Therapeutics
Series B in 2024
Founded in 2022, Pheon Therapeutics specializes in developing Antibody-Drug Conjugates (ADCs) for challenging-to-treat cancers. Its primary focus is a first-in-class ADC targeting a novel marker overexpressed in various solid tumors.
Triomics is a generative AI-powered platform focused on enhancing oncology research and clinical trial operations. By streamlining processes such as patient recruitment and data collection, the company aims to accelerate trial enrollment and improve quality assurance in healthcare. Its advanced AI technology, which is adept at understanding health records and medical terminology, serves as a foundation for its services. Triomics targets operational inefficiencies common in clinical research, thereby enabling pharmaceutical companies and contract research organizations to conduct more efficient and cost-effective clinical trials. The platform ultimately seeks to enhance the overall effectiveness of oncology care and research.
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.
Zocks, established in 2022 and based in San Francisco, specializes in real-time video call insights and privacy. The company's core product is a communication management platform, which captures and analyzes industry-specific insights from client conversations. Key features include claim code tracking, data entry reduction, session insights, HIPAA compliance, and API references, helping clients streamline workflows and extract valuable data from conversations.
Anatomy Financial
Seed Round in 2024
Anatomy Financial specializes in streamlining financial operations for healthcare organizations that bill insurance. Their core offering is an AI-driven platform that automates financial workflows, including automated conversion of Explanation of Benefits (EOBs), intelligent reconciliation, and a modern healthcare lockbox system. This platform integrates and analyzes bank, claims, and accounting data in real-time, providing actionable financial insights and automating reconciliation processes. By doing so, Anatomy Financial enables healthcare providers to focus more on patient care.
Emversity
Venture Round in 2023
Emversity is an education organization focused on preparing students for careers in Allied Health Sciences. It offers vocational courses tailored to industry needs, aiming to bridge the gap between education and employment.
Founded in 2021, Ketryx is headquartered in Cambridge, Massachusetts. It empowers regulated software teams to deliver safer software faster by providing an AI-driven compliance platform that integrates with popular tools like Jira and GitHub. This platform generates FDA-ready documentation, maintains traceability across systems, and enforces quality procedures.
Seismic Therapeutic
Series B in 2023
Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.
Olema Oncology
Post in 2023
Olema Oncology is a preclinical biotechnology company dedicated to developing innovative therapies for the treatment and prevention of estrogen receptor-positive breast cancer. The company specializes in discovering and commercializing targeted treatments specifically designed for women's cancers. By leveraging its extensive understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance, Olema aims to create compounds that surpass existing therapies. The company's focus is on transforming the standard of care for both pre- and post-menopausal women with cancer, with an emphasis on developing more effective and convenient treatment options. Olema's pipeline includes drug candidates such as OP-1250 and OP-3136, which have progressed through discovery and preclinical studies.
Daybreak Health
Series B in 2023
Founded in 2019, Daybreak Health specializes in providing online counseling services tailored for teenagers. Through its mobile app, the company connects teens with therapists who focus on issues such as anxiety, depression, stress management, and building self-esteem.
Berry Health
Pre Seed Round in 2023
Berry Health is a consumer health startup specializing in remote diagnosis and treatment of various chronic medical conditions. It offers online private medical consultations, prescription drugs, and nationwide delivery, aiming to improve patients' lives by addressing under-served and stigmatized conditions while increasing patient agency.
Aledade is a health technology and services platform that partners with independent primary care physicians to form and operate Accountable Care Organizations in the United States. It provides data analytics, guided workflows, regulatory and contracting support, payer relationships, and local on-the-ground expertise to help practices transform operations, optimize care delivery, and align incentives around value-based care. The platform integrates care data across the continuum, offers practice management tools, and supports governance and policy guidance to enable autonomous physician groups—from small practices to multispecialty networks and community health centers—to improve patient outcomes while reducing overall costs. Headquartered in Bethesda, Maryland, the company was founded in 2014.
HealthPlix
Series C in 2023
HealthPlix is a pioneering company in the digitization of healthcare in India, offering an AI-powered electronic medical record (EMR) platform designed to enhance clinical decision-making for doctors. The platform currently supports over 10,000 physicians across more than 370 cities, enabling them to deliver improved health outcomes for their patients. With the treatment of over 22 million patients across 16 medical specialties, HealthPlix facilitates personalized consultations based on individual medical histories, particularly focusing on chronic conditions like diabetes. By replacing traditional pen-and-paper prescriptions with an efficient digital system, HealthPlix empowers healthcare professionals to streamline their practices and improve patient care.
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.
Soda Health
Series A in 2022
Founded in 2021, Soda Health is a Chicago-based healthcare technology company committed to reducing health disparities by addressing social determinants of health. It operates a platform that delivers personalized benefits, providing real-time access to essential services such as healthy food, over-the-counter medications, and transportation.
Theranica
Series C in 2022
Theranica is a medical device company specializing in the development of electroceuticals that utilize neuromodulation therapy combined with advanced wireless technology. The company has created a proprietary wearable solution, specifically a non-invasive 'smart' patch, designed to address various medical conditions, with a primary focus on migraine headaches. This innovative product is controlled via a smartphone app, allowing for personalized and portable treatment options. The patch features a unique 'smart' chip that delivers electrical pulses to modulate the sensory nerves beneath the skin, offering patients an effective means of managing acute migraines. Theranica's solutions aim to provide affordable care and enhance the quality of life for individuals suffering from neurological pain.
WonderMind
Seed Round in 2022
Wondermind is a mental fitness ecosystem founded by Selena Gomez, Mandy Teefey, and Daniella Pierson, dedicated to democratizing and destigmatizing mental health. The company offers a platform that provides accessible and affordable mental health care through daily engaging content, consumer packaged goods, and storytelling. Users receive customized peer-to-peer support and resources designed to enhance their understanding of mental wellness. By focusing on practical and achievable methods for prioritizing mental fitness, Wondermind aims to empower individuals to improve their well-being and capitalize on their strengths.
Ancora Biotech
Series A in 2022
Ancora Biotech develops antibody biotherapeutics drugs targeting B cell cancers, inflammatory disorders, metabolic conditions, and chronic hepatitis B infections. Their focus is on clinical development support, aiming to enable healthcare professionals to provide effective treatments for various life-threatening diseases.
ImmunOs Therapeutics
Series B in 2022
ImmunOs Therapeutics is a clinical-stage biotechnology company focused on discovering and developing novel human immunomodulatory proteins and therapies for cancer and autoimmune diseases. The company aims to enhance cancer treatment by leveraging proteins with direct anti-tumor effects that remodel the tumor microenvironment and by developing antibodies that block activation of specific HLA molecules implicated in autoimmune conditions. Founded in 2014 and based in Schlieren, Switzerland, ImmunOs Therapeutics pursues next-generation therapeutics intended to improve outcomes for patients with serious diseases.
Air Doctor
Series B in 2022
Air Doctor Ltd. operates an online marketplace that connects travelers with verified healthcare professionals in various locations. Founded in 2016 and based in Motza Illit, Israel, the platform allows users to search for and schedule appointments with doctors, dentists, emergency clinics, pharmacies, and other healthcare specialists. By providing access to practitioner profiles and patient reviews, Air Doctor simplifies the process of obtaining medical care abroad, ensuring that users can find professionals who speak their language and meet their specific needs. This service aims to enhance the experience of travelers by making healthcare access straightforward and efficient in unfamiliar destinations.
Founded in 2019, Zeera is a mental healthcare company based in New York. It offers a digital platform focused on member-centered care, providing affordable and effective therapy services. The platform aims to redesign mental health care by integrating empathy, design, and progressive care.
NyquistAI
Seed Round in 2022
NyquistAI is a developer of a global data platform that specializes in transforming unstructured life science data into actionable insights. By leveraging advanced machine learning technology, NyquistAI connects various data sources, including global clinical trials and real-world information, to offer a comprehensive view of the Medtech landscape. The platform is designed to help healthcare professionals access and compile critical life science data, enabling them to make informed decisions in research and business strategy development. NyquistAI aims to provide a customizable experience that equips users with credible, up-to-date content and expertise throughout the entire innovation lifecycle, thereby facilitating enhanced research and the identification of new opportunities within the life sciences sector.
Kirilys Therapeutics
Seed Round in 2022
Kirilys is a biopharmaceutical company focused on developing precision oncology assets aimed at improving the quality of life for cancer patients. Currently in the preclinical stages, the firm is working on a drug that has shown promising potency, selectivity, and anti-tumor efficacy. This drug is designed to be administered orally, which may enhance its usability for clinicians. In addition to addressing various cancers, Kirilys is also dedicated to improving treatment options for patients with chronic kidney disease. Through its innovative approach, the company aims to contribute significantly to the field of oncology and patient care.
Daybreak Health
Series A in 2022
Founded in 2019, Daybreak Health specializes in providing online counseling services tailored for teenagers. Through its mobile app, the company connects teens with therapists who focus on issues such as anxiety, depression, stress management, and building self-esteem.
MDClone Ltd. is a company that specializes in software development for analyzing medical records. Founded in 2016 and based in Beersheba, Israel, MDClone has created a platform that generates synthetic medical records for fictitious patients, thus mitigating the risk of disclosing actual patient data. This innovative platform, known as ADAMS, provides a self-service analytics environment that facilitates exploration and collaboration across the healthcare ecosystem. By enabling researchers and healthcare organizations to examine disease behaviors, treatment efficacy, and operational efficiencies, MDClone supports the advancement of medical research and improves patient outcomes while ensuring the protection of sensitive medical information. The company serves a diverse clientele that includes major health systems, payers, and life sciences organizations in the United States, Canada, and Israel.
Seismic Therapeutic
Series A in 2022
Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.
Curve Health
Series A in 2022
Curve Health, Inc. is an innovative online platform focused on enhancing senior care by integrating telemedicine, health information exchange, smart billing, and predictive analytics. Established in 2020 and headquartered in New York, the company aims to improve healthcare delivery for seniors by facilitating remote patient care across various settings, including skilled nursing facilities, homes, and ambulances. Curve Health's platform has successfully reduced patient transfers from skilled nursing facilities to emergency departments by over 50%. It streamlines care coordination between hospital systems and post-acute facilities, automates billing processes, and enhances the tracking of patient diagnoses and outcomes. By bridging existing gaps in healthcare delivery, Curve Health seeks to optimize resource allocation, minimize readmissions, and ensure a seamless experience for patients, ultimately leading to improved care quality and financial returns for healthcare providers.
MAYD Group is a startup focused on providing rapid medication delivery services. The company operates a platform that facilitates the delivery of pharmacy products directly to customers' doorsteps. By partnering with local pharmacies, MAYD Group enables users to access a wide range of medical products quickly and efficiently. The service is designed to meet users' medical needs conveniently while ensuring they receive competent advice and support throughout the process.
Wheel, Inc. is a digital health company based in Austin, Texas, that operates a tech-enabled marketplace connecting healthcare companies with clinicians. Founded in 2018, the company focuses on telehealth services, providing a platform that allows healthcare organizations to easily scale their virtual care offerings. Wheel's platform leverages machine learning algorithms to streamline the process for companies seeking to develop virtual care services under their own brand. By facilitating access to a nationwide network of clinicians, Wheel enhances opportunities for healthcare professionals while delivering quality digital healthcare solutions. Formerly known as Enzyme Health, Inc., the company rebranded to Wheel, Inc. in January 2020.
Acko is a digital insurance provider that streamlines the underwriting and distribution of various insurance products through its online platform. The company specializes in personalized insurance offerings, leveraging data and analytics to tailor its products to user consumption behaviors. Acko offers a range of bite-sized insurance solutions, primarily targeting drivers and professionals within the transportation sector, while also expanding into healthcare with policies related to employee health benefits and wellness. Its approach aims to simplify the insurance buying experience, making it transparent and efficient for consumers.
NeuralGalaxy
Series A in 2021
Neural Galaxy is a brain science company that emerged from Harvard Medical School and the Massachusetts Institute of Technology. The organization focuses on addressing brain disorders through advanced software and hardware technologies. By leveraging breakthrough research in brain science, Neural Galaxy aims to enhance understanding of the brain and high-level intelligence. Its mission includes tackling significant challenges related to brain diseases and improving treatment options, ultimately contributing to a deeper comprehension of human cognition and enhancing overall societal intelligence.
Soda Health
Seed Round in 2021
Founded in 2021, Soda Health is a Chicago-based healthcare technology company committed to reducing health disparities by addressing social determinants of health. It operates a platform that delivers personalized benefits, providing real-time access to essential services such as healthy food, over-the-counter medications, and transportation.
Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.
3T Biosciences
Series A in 2021
Founded in 2017, 3T Biosciences is a biotechnology company based in Menlo Park, California. It specializes in immunotherapies for cancer treatment.
Shanghai LinkedCare Information Technology
Series D in 2021
Shanghai LinkedCare Information Technology Co., Ltd. is a company that specializes in developing oral intelligence management software and integrated management systems tailored for dental clinics and medical beauty institutions. Founded in 2015 and based in Shanghai, the company offers a comprehensive dental cloud management solution that includes features such as electronic signatures, member management, treatment planning, clinic analysis, chain management, and inventory oversight. Additionally, it provides medical beauty cloud management solutions, encompassing marketing tools, member management, cashier systems, appointment scheduling, and analytical management. LinkedCare aims to fully automate the digital operations of consumer medical institutions, promoting standardization in management and treatment, enhancing marketing capabilities, and facilitating mobile office solutions. Through its services, the company helps institutions improve operational efficiency, increase revenue, and manage risks effectively.
Abata Therapeutics
Series A in 2021
Abata Therapeutics is a biotechnology company dedicated to developing innovative cell therapies for patients suffering from progressive multiple sclerosis and other severe autoimmune and inflammatory diseases. The company specializes in the manipulation of regulatory T cells (Tregs) to address these conditions, aiming to restore balance within the immune system. By engineering Tregs to precisely target disease-related antigens, Abata Therapeutics creates therapies that can effectively treat diseases such as multiple sclerosis and type 1 diabetes without imposing systemic immune suppression. Founded by experts in immunology and cell therapy, Abata is committed to translating advanced scientific research into meaningful therapies that improve the lives of individuals facing chronic autoimmune challenges.
Wheel, Inc. is a digital health company based in Austin, Texas, that operates a tech-enabled marketplace connecting healthcare companies with clinicians. Founded in 2018, the company focuses on telehealth services, providing a platform that allows healthcare organizations to easily scale their virtual care offerings. Wheel's platform leverages machine learning algorithms to streamline the process for companies seeking to develop virtual care services under their own brand. By facilitating access to a nationwide network of clinicians, Wheel enhances opportunities for healthcare professionals while delivering quality digital healthcare solutions. Formerly known as Enzyme Health, Inc., the company rebranded to Wheel, Inc. in January 2020.
Founded in 2019, Zeera is a mental healthcare company based in New York. It offers a digital platform focused on member-centered care, providing affordable and effective therapy services. The platform aims to redesign mental health care by integrating empathy, design, and progressive care.
HealthPlix
Series B in 2021
HealthPlix is a pioneering company in the digitization of healthcare in India, offering an AI-powered electronic medical record (EMR) platform designed to enhance clinical decision-making for doctors. The platform currently supports over 10,000 physicians across more than 370 cities, enabling them to deliver improved health outcomes for their patients. With the treatment of over 22 million patients across 16 medical specialties, HealthPlix facilitates personalized consultations based on individual medical histories, particularly focusing on chronic conditions like diabetes. By replacing traditional pen-and-paper prescriptions with an efficient digital system, HealthPlix empowers healthcare professionals to streamline their practices and improve patient care.
MingMed is a Chinese pharmaceutical company focused on independent drug research and development, demonstrating strong global competitiveness. The company specializes in a diverse product pipeline that includes ophthalmic drugs, recombinant protein botulinum toxin, tumor immune drugs, and immune therapies for pets. MingMed also emphasizes innovation, with several potential First-in-Class drugs currently in the clinical stage. Its research spans various therapeutic areas, delivering cutting-edge solutions in ophthalmology, medical aesthetics, and veterinary medicine, particularly through small molecule immune drugs and gene editing-based cell therapies.
Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.
Radicle Science
Pre Seed Round in 2021
Radicle Science operates a clinical research platform focused on generating real-world evidence for non-prescription health products. The platform conducts large-scale, double-blind, randomized controlled trials, collects unblended consumer health data, and applies biostatistics and AI to deliver insights on product effectiveness.
Freespira
Series D in 2020
Freespira specializes in digital therapeutics for behavioral health. Its primary product, Freespira®, is an FDA-cleared device that helps users manage panic attacks, panic disorder, and PTSD symptoms by training them to regulate their breathing patterns.
Curve Health
Seed Round in 2020
Curve Health, Inc. is an innovative online platform focused on enhancing senior care by integrating telemedicine, health information exchange, smart billing, and predictive analytics. Established in 2020 and headquartered in New York, the company aims to improve healthcare delivery for seniors by facilitating remote patient care across various settings, including skilled nursing facilities, homes, and ambulances. Curve Health's platform has successfully reduced patient transfers from skilled nursing facilities to emergency departments by over 50%. It streamlines care coordination between hospital systems and post-acute facilities, automates billing processes, and enhances the tracking of patient diagnoses and outcomes. By bridging existing gaps in healthcare delivery, Curve Health seeks to optimize resource allocation, minimize readmissions, and ensure a seamless experience for patients, ultimately leading to improved care quality and financial returns for healthcare providers.
Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.
Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.
SoupMaster
Series A in 2020
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.
Orca Bio is a clinical-stage cell therapy company focused on providing curative treatments for patients with various malignant and autoimmune diseases. The company has developed a range of proprietary technologies aimed at replacing diseased blood and immune systems with healthy ones. By specializing in the research and development of innovative cell therapies, Orca Bio seeks to transform the landscape of bone marrow transplantation. Its advanced therapeutic platform is designed to empower healthcare professionals in effectively treating patients, thereby addressing a significant unmet medical need. The company is backed by a team of leading experts and technologists committed to realizing its vision of delivering life-saving medical solutions.
Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.
NeuralGalaxy
Seed Round in 2020
Neural Galaxy is a brain science company that emerged from Harvard Medical School and the Massachusetts Institute of Technology. The organization focuses on addressing brain disorders through advanced software and hardware technologies. By leveraging breakthrough research in brain science, Neural Galaxy aims to enhance understanding of the brain and high-level intelligence. Its mission includes tackling significant challenges related to brain diseases and improving treatment options, ultimately contributing to a deeper comprehension of human cognition and enhancing overall societal intelligence.
Hevo Data
Seed Round in 2019
Hevo Data Inc. is a software-as-a-service company specializing in data integration services. Founded in 2016, the company has developed a platform that allows users to connect and transfer data between various sources and destinations, including databases, cloud storage, and applications. Hevo's platform also facilitates data analysis across multiple formats and silos, catering to a diverse range of industries such as fintech, hospitality, e-commerce, healthcare, and edtech. Headquartered in San Francisco, California, Hevo Data also maintains an office in Bengaluru, India, enhancing its global reach and operational capabilities.
MDClone Ltd. is a company that specializes in software development for analyzing medical records. Founded in 2016 and based in Beersheba, Israel, MDClone has created a platform that generates synthetic medical records for fictitious patients, thus mitigating the risk of disclosing actual patient data. This innovative platform, known as ADAMS, provides a self-service analytics environment that facilitates exploration and collaboration across the healthcare ecosystem. By enabling researchers and healthcare organizations to examine disease behaviors, treatment efficacy, and operational efficiencies, MDClone supports the advancement of medical research and improves patient outcomes while ensuring the protection of sensitive medical information. The company serves a diverse clientele that includes major health systems, payers, and life sciences organizations in the United States, Canada, and Israel.
Theranica
Series B in 2019
Theranica is a medical device company specializing in the development of electroceuticals that utilize neuromodulation therapy combined with advanced wireless technology. The company has created a proprietary wearable solution, specifically a non-invasive 'smart' patch, designed to address various medical conditions, with a primary focus on migraine headaches. This innovative product is controlled via a smartphone app, allowing for personalized and portable treatment options. The patch features a unique 'smart' chip that delivers electrical pulses to modulate the sensory nerves beneath the skin, offering patients an effective means of managing acute migraines. Theranica's solutions aim to provide affordable care and enhance the quality of life for individuals suffering from neurological pain.
SleepSpace
Venture Round in 2018
SleepSpace is a pioneering company that has developed the first Sleep Operating System aimed at transforming the smart bedroom with integrated technologies. By harnessing the science of sound, vibration, and light, SleepSpace enhances the sleep experience and offers more accurate sleep measurements than traditional wearables. Its proprietary nearable sensing technology allows smartphones to function as smart beds, providing valuable insights for both users and clinicians. The company's platform enables healthcare professionals to deliver personalized sleep programs while gaining comprehensive data on patients' sleep patterns. SleepSpace has established partnerships with major mattress brands, hotels, and corporate wellness initiatives, underscoring its commitment to improving sleep health. Additionally, the company has received substantial funding through grants from the National Institutes of Health, further validating its innovative approach to sleep improvement.
TeneoBio
Venture Round in 2018
TeneoBio, Inc. is a biotechnology company based in Menlo Park, California, specializing in the development of human heavy chain antibodies, known as UniAbs, for therapeutic applications. Founded in 2009, the company focuses on creating biologics to treat various conditions, including cancer, autoimmune diseases, and infectious diseases. TeneoBio has a pipeline of products in both pre-clinical and clinical stages, targeting ailments such as multiple myeloma, prostate cancer, and immune disorders. The company employs a proprietary antibody discovery platform that utilizes genetically engineered animals, next-generation sequencing, and advanced bioinformatics to identify unique binding molecules tailored for specific therapeutic targets. This innovative approach aims to enhance the immune response in patients and address significant health challenges.
InnovAccer
Series B in 2018
InnovAccer develops and delivers analytical applications for various industries, specializing in healthcare. Its flagship platform, Datashop, offers solutions like Datashop Care for targeted patient care, Datashop Alchemy for market risk analysis, and Datashop Insights for data visualization. InnovAccer also provides tools for clinical documentation improvement, physician engagement, and care navigation. The company serves academic institutions, governmental organizations, and corporate enterprises globally.
SoupMaster
Series A in 2018
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.
MDClone Ltd. is a company that specializes in software development for analyzing medical records. Founded in 2016 and based in Beersheba, Israel, MDClone has created a platform that generates synthetic medical records for fictitious patients, thus mitigating the risk of disclosing actual patient data. This innovative platform, known as ADAMS, provides a self-service analytics environment that facilitates exploration and collaboration across the healthcare ecosystem. By enabling researchers and healthcare organizations to examine disease behaviors, treatment efficacy, and operational efficiencies, MDClone supports the advancement of medical research and improves patient outcomes while ensuring the protection of sensitive medical information. The company serves a diverse clientele that includes major health systems, payers, and life sciences organizations in the United States, Canada, and Israel.
SoupMaster
Series A in 2017
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.
Forty Seven
Series B in 2017
Forty Seven, Inc. is a clinical-stage immuno-oncology company headquartered in Menlo Park, California, focused on developing innovative therapies to activate macrophages for cancer treatment. The company’s lead product, magrolimab, is a humanized monoclonal antibody targeting the CD47 receptor, which tumors exploit to evade immune detection. Magrolimab is currently undergoing Phase 1b/2 clinical trials for various cancers, including solid tumors and hematologic malignancies such as acute myeloid leukemia and non-Hodgkin's lymphoma. Additionally, Forty Seven is advancing other antibody-based therapies, including FSI-189, which targets SIRPa, and FSI-174, an anti-cKIT antibody. The company collaborates with Genentech and Acerta Pharma to explore further applications of its therapies in combination with other cancer treatments. Founded in 2014 and previously known as CD47 Sciences, Inc., Forty Seven operates as a subsidiary of Gilead Sciences, Inc.
Cairns Health
Seed Round in 2017
Cairns Health is a digital care companion and enablement platform for senior living and home care. The company's digital care plan enablement solution integrates intelligent ambient sensing (radar), artificial intelligence (AI) and large language models (LLM's) to streamline caregiver-patient interactions, boost engagement, and empower patients with a better understanding of their care plans, leading to timely interventions that improve care while reducing overall care delivery costs.
Theranica
Series A in 2017
Theranica is a medical device company specializing in the development of electroceuticals that utilize neuromodulation therapy combined with advanced wireless technology. The company has created a proprietary wearable solution, specifically a non-invasive 'smart' patch, designed to address various medical conditions, with a primary focus on migraine headaches. This innovative product is controlled via a smartphone app, allowing for personalized and portable treatment options. The patch features a unique 'smart' chip that delivers electrical pulses to modulate the sensory nerves beneath the skin, offering patients an effective means of managing acute migraines. Theranica's solutions aim to provide affordable care and enhance the quality of life for individuals suffering from neurological pain.
Collectly
Pre Seed Round in 2017
Founded in 2016, Collectly specializes in debt recovery software for businesses. Its flagship product automatically tracks overdue payments, communicates with customers via email or chat, and facilitates direct payment receipts. Collectly also offers solutions tailored to healthcare organizations, helping them automate revenue cycle operations, boost patient collection rates, and enhance the patient financial experience.
Comprehend Systems
Series C in 2017
Comprehend Systems, Inc. is a Redwood City, California-based company that specializes in cloud-based continuous quality solutions for clinical operations. Founded in 2010, the company offers a comprehensive suite of clinical intelligence applications designed to enhance the efficiency, safety, and quality of clinical trials. These applications cater to clinical operations executives, data managers, and medical monitors, providing tools for portfolio monitoring, continuous quality assessment, collaboration with contract research organizations (CROs), and risk and medical monitoring. Comprehend Systems aims to deliver actionable insights across studies, systems, sites, and vendors, thereby improving the overall clinical trial process. In 2019, it became a subsidiary of Saama Technologies, Inc.
PlushCare
Series A in 2016
PlushCare, Inc. is a telemedicine provider based in San Francisco, California, specializing in virtual primary care and mental health treatment services. Founded in 2013, the company offers a technology platform that enables patients to connect with board-certified doctors via video chat for diagnoses, treatment plans, and prescriptions. PlushCare's services cater to various medical needs, including chronic conditions and urgent care, allowing users to easily schedule online appointments. The platform has garnered a positive reputation, serving over 100,000 patients and achieving a high Net Promoter Score, reflecting strong customer satisfaction. Additionally, PlushCare has been involved in developing at-home Coronavirus testing solutions, further contributing to its commitment to accessible healthcare.
InnovAccer
Series A in 2016
InnovAccer develops and delivers analytical applications for various industries, specializing in healthcare. Its flagship platform, Datashop, offers solutions like Datashop Care for targeted patient care, Datashop Alchemy for market risk analysis, and Datashop Insights for data visualization. InnovAccer also provides tools for clinical documentation improvement, physician engagement, and care navigation. The company serves academic institutions, governmental organizations, and corporate enterprises globally.
Evariant, Inc. is a healthcare technology company that offers a comprehensive platform designed to enhance patient acquisition and retention for healthcare organizations. Founded in 2008 and based in Farmington, Connecticut, Evariant provides a suite of solutions that includes tools for understanding patient demographics, managing marketing campaigns, and fostering engagement with both patients and physicians. Its offerings encompass Patient Market Solver for data analysis, multi-channel CRM solutions for targeted growth, and physician relationship management tools to improve collaboration and recruitment. Additionally, Evariant supports healthcare providers with campaign services, digital media solutions, and professional training. The company aims to deliver actionable insights and improve the effectiveness of marketing strategies, thereby optimizing growth and enhancing the overall patient experience. Evariant serves over 1,000 hospitals nationwide, positioning itself as a trusted partner in the healthcare sector.
Zhangshang Yaodian
Series B in 2016
Zhangshang Yaodian is a pharmacy app that provides safe medication services.
Forty Seven
Series A in 2016
Forty Seven, Inc. is a clinical-stage immuno-oncology company headquartered in Menlo Park, California, focused on developing innovative therapies to activate macrophages for cancer treatment. The company’s lead product, magrolimab, is a humanized monoclonal antibody targeting the CD47 receptor, which tumors exploit to evade immune detection. Magrolimab is currently undergoing Phase 1b/2 clinical trials for various cancers, including solid tumors and hematologic malignancies such as acute myeloid leukemia and non-Hodgkin's lymphoma. Additionally, Forty Seven is advancing other antibody-based therapies, including FSI-189, which targets SIRPa, and FSI-174, an anti-cKIT antibody. The company collaborates with Genentech and Acerta Pharma to explore further applications of its therapies in combination with other cancer treatments. Founded in 2014 and previously known as CD47 Sciences, Inc., Forty Seven operates as a subsidiary of Gilead Sciences, Inc.
Evariant, Inc. is a healthcare technology company that offers a comprehensive platform designed to enhance patient acquisition and retention for healthcare organizations. Founded in 2008 and based in Farmington, Connecticut, Evariant provides a suite of solutions that includes tools for understanding patient demographics, managing marketing campaigns, and fostering engagement with both patients and physicians. Its offerings encompass Patient Market Solver for data analysis, multi-channel CRM solutions for targeted growth, and physician relationship management tools to improve collaboration and recruitment. Additionally, Evariant supports healthcare providers with campaign services, digital media solutions, and professional training. The company aims to deliver actionable insights and improve the effectiveness of marketing strategies, thereby optimizing growth and enhancing the overall patient experience. Evariant serves over 1,000 hospitals nationwide, positioning itself as a trusted partner in the healthcare sector.
Xingren Doctor
Series B in 2015
In China, almost every doctor must face overloaded with work. The number of patients they received a day or even a week,the number of foreign doctors will be reception. In addition to China's large population of natural conditions, the unity of the health care system, pattern, so difficult and tense doctor-patient relationship and other issues remain unresolved.
Tencent Trusted Doctors
Series B in 2015
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".
Kuai Heatlh Direct
Angel Round in 2014
Kuai Health Direct is a company that specializes in on-demand food delivery services, focusing on the sale of specific nutritious foods. It operates a mobile commerce platform that facilitates the integration of food providers and retail channels, enhancing their online-to-offline operations. The company is notable for its self-built logistics model, which enables a fast delivery service, potentially within one hour. This approach aims to streamline the purchasing process for health-conscious consumers seeking quick access to nutritious meal options.
Comprehend Systems
Series B in 2014
Comprehend Systems, Inc. is a Redwood City, California-based company that specializes in cloud-based continuous quality solutions for clinical operations. Founded in 2010, the company offers a comprehensive suite of clinical intelligence applications designed to enhance the efficiency, safety, and quality of clinical trials. These applications cater to clinical operations executives, data managers, and medical monitors, providing tools for portfolio monitoring, continuous quality assessment, collaboration with contract research organizations (CROs), and risk and medical monitoring. Comprehend Systems aims to deliver actionable insights across studies, systems, sites, and vendors, thereby improving the overall clinical trial process. In 2019, it became a subsidiary of Saama Technologies, Inc.
Tencent Trusted Doctors
Series A in 2014
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".
Acupera Inc. is a digital health company based in San Francisco, California, specializing in population health and care coordination solutions for healthcare provider organizations. Founded in 2011, Acupera offers a platform that connects diverse healthcare teams to deliver patient-centric care through integrated care plans. Its services include population health advisory, an integration engine for data from electronic health records, labs, and remote monitoring, as well as tools for analytics, reporting, and referral network management. Acupera's technology helps healthcare providers efficiently manage their patient populations, ultimately supporting value-based contracts and accountable care organizations. The company aims to enhance the quality of care while assisting providers in meeting their operational and performance objectives.
Cognito
Seed Round in 2014
Cognito is a technology company specializing in intelligent identity verification solutions. Founded in 2013 and based in Palo Alto, California, Cognito offers an identity verification platform that enables businesses to verify customer identities through APIs. The platform checks essential data such as names, dates of birth, addresses, and identification numbers to ensure compliance with Know Your Customer (KYC) regulations and to mitigate fraud risks. Cognito's services cater to various industries, including crowdfunding, virtual currency, healthcare, and on-demand services. Originally established as BlockScore, Inc., the company rebranded to Cognito in 2014, emphasizing its commitment to providing a developer-friendly solution that addresses common frustrations associated with identity verification processes.
Evariant, Inc. is a healthcare technology company that offers a comprehensive platform designed to enhance patient acquisition and retention for healthcare organizations. Founded in 2008 and based in Farmington, Connecticut, Evariant provides a suite of solutions that includes tools for understanding patient demographics, managing marketing campaigns, and fostering engagement with both patients and physicians. Its offerings encompass Patient Market Solver for data analysis, multi-channel CRM solutions for targeted growth, and physician relationship management tools to improve collaboration and recruitment. Additionally, Evariant supports healthcare providers with campaign services, digital media solutions, and professional training. The company aims to deliver actionable insights and improve the effectiveness of marketing strategies, thereby optimizing growth and enhancing the overall patient experience. Evariant serves over 1,000 hospitals nationwide, positioning itself as a trusted partner in the healthcare sector.
EPINOMICS
Funding Round in 2014
Epinomics Inc. specializes in advancing personalized medicine by leveraging big data analytics and proprietary epigenomics technology. Founded in 2013 and located in Menlo Park, California, the company focuses on decoding the human genome to enhance drug development and clinical applications. By utilizing innovative DNA sequencing technology, Epinomics aims to improve existing methodologies in the field, facilitating deeper scientific research and the development of clinical applications. As of March 31, 2018, Epinomics operates as a subsidiary of 10X Genomics, Inc., furthering its mission to revolutionize healthcare through precision medicine.
Xingren Doctor
Series A in 2014
In China, almost every doctor must face overloaded with work. The number of patients they received a day or even a week,the number of foreign doctors will be reception. In addition to China's large population of natural conditions, the unity of the health care system, pattern, so difficult and tense doctor-patient relationship and other issues remain unresolved.
Tencent Trusted Doctors
Angel Round in 2013
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".
Cognito
Seed Round in 2013
Cognito is a technology company specializing in intelligent identity verification solutions. Founded in 2013 and based in Palo Alto, California, Cognito offers an identity verification platform that enables businesses to verify customer identities through APIs. The platform checks essential data such as names, dates of birth, addresses, and identification numbers to ensure compliance with Know Your Customer (KYC) regulations and to mitigate fraud risks. Cognito's services cater to various industries, including crowdfunding, virtual currency, healthcare, and on-demand services. Originally established as BlockScore, Inc., the company rebranded to Cognito in 2014, emphasizing its commitment to providing a developer-friendly solution that addresses common frustrations associated with identity verification processes.
Natera, Inc. is a diagnostic and research company specializing in genetic testing services, particularly in the areas of preconception and prenatal diagnostics. Founded in 2003 and headquartered in San Carlos, California, Natera offers a range of products including the Panorama non-invasive prenatal test, which screens for chromosomal abnormalities in fetuses, and Vistara, a test for single-gene mutations. Additionally, the company provides Horizon carrier screening to assess carrier status for various genetic diseases, and Spectrum, which analyzes genetic conditions during in vitro fertilization. Natera's Anora product analyzes fetal chromosomes to understand miscarriage causes, while its non-invasive paternity tests determine parentage through fetal DNA analysis. The company's Signatera technology focuses on circulating tumor DNA to monitor cancer recurrence. Natera distributes its products through a direct sales force and a network of approximately 100 laboratory and distribution partners, both domestically and internationally. The company collaborates with BGI Genomics to develop genetic testing assays and has partnered with Foundation Medicine for personalized cancer monitoring assays.
Nimble Storage
Series E in 2012
Nimble Storage, Inc. specializes in providing flash storage platforms designed to enhance the performance of various business applications. The company's offerings include InfoSight, a predictive cloud platform that integrates predictive analytics with flash storage and multicloud infrastructure, streamlining operations in both on-premises data centers and cloud environments. Nimble Storage's product line features AF-Series All Flash arrays and CS-Series Adaptive Flash arrays, which are optimized for high-I/O applications such as Oracle and SQL Server. Additionally, Nimble Cloud Volumes deliver an enterprise-grade multi-cloud storage solution that supports applications in major cloud environments like Amazon Web Services and Microsoft Azure. The company markets its products through a network of value-added resellers, system integrators, and distributors across diverse sectors, including healthcare, education, financial services, and technology. Founded in 2007 and headquartered in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.
HealthPocket
Series A in 2012
HealthPocket is a technology company that specializes in comparing and ranking health insurance plans available to consumers. Through its web portal, HealthPocket enables users to search for health plans in their local area, facilitating the selection of options based on quality and cost. The platform integrates quality ratings from government and non-profit organizations with its own proprietary ranking system, allowing consumers to identify the highest quality and lowest priced health insurance. By streamlining the process of comparing health plans, HealthPocket aims to help individuals save on out-of-pocket healthcare costs.